Wuhan Healthgen Biotechnology Corp. (SHA:688765)
China flag China · Delayed Price · Currency is CNY
71.25
-0.57 (-0.79%)
At close: Mar 9, 2026

SHA:688765 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Debt / Equity Ratio
1.220.370.130.020.000.05
Upgrade
Net Debt / Equity Ratio
1.070.10-0.19-0.42-0.53-0.68
Upgrade
Net Debt / EBITDA Ratio
-4.60-0.580.892.472.002.67
Upgrade
Net Debt / FCF Ratio
-1.13-0.280.630.880.923.82
Upgrade
Asset Turnover
-0.030.020.020.060.12
Upgrade
Inventory Turnover
-0.230.400.320.770.49
Upgrade
Quick Ratio
0.200.691.962.031.868.41
Upgrade
Current Ratio
0.641.022.392.352.159.48
Upgrade
Return on Equity (ROE)
--22.71%-22.98%-21.20%-40.16%-38.30%
Upgrade
Return on Assets (ROA)
--10.28%-12.57%-12.02%-19.69%-22.51%
Upgrade
Return on Capital Employed (ROCE)
-16.30%-20.10%-24.70%-17.90%-28.40%-28.30%
Upgrade
Buyback Yield / Dilution
-1.21%-1.20%-2.31%-20.75%-333.57%-4.84%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.